Reed Heimbecher and Tania Shapiro-Barr Author Article for Metropolitan Corporate Counsel

Reed R. Heimbecher and Tania Shapiro-Barr, Minneapolis-based attorneys and members of Dykema’s Intellectual Property Practice Group, co-authored the article, “Biosimilars: Poised to Turn in Inter Partes Review to Resolve Patent Disputes,” which appeared in the June issue of Metropolitan Corporate Counsel.

In the article, Heimbecher and Shapiro-Barr discuss biosimilars—a biological product that is highly similar to an existing FDA-approved biological product and exhibits no clinically meaningful difference in terms of safety, purity or potency—and how applicants are likely eyeing inter partes review as a more favorable option for resolving patent disputes.

To read the entire article, click here.